Skip to main content
NIH funding notice PA-18-939

Research on Chronic Overlapping Pain Conditions (R21 Clinical Trial Not Allowed)

Closed on May 7, 2022.

Posted
September 26, 2018
Close date
May 7, 2022
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $421,325 in first-year total cost, median $210,663.

Most frequent study sections

  1. Kidney and Urological Systems Function and Dysfunction Study Section[KUFD]1
  2. Neurological, Aging and Musculoskeletal Epidemiology Study Section[NAME]1

Most frequent institutions

  1. LOYOLA UNIVERSITY CHICAGO1
  2. UNIV OF NORTH CAROLINA CHAPEL HILL1
Competing awards under PA-18-939 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2022Musculoskeletal and Pelvic Floor Health in Female Chronic Overlapping Pelvic Pain Conditions (The MSK-PELVIC Study)1R21HD105115-01A1FITZGERALD, COLLEEN MARIELOYOLA UNIVERSITY CHICAGO, IL$226,950KUFD
2020Potential mechanisms underlying a relationship between long-chain polyunsaturated fatty acids and overlapping pain conditions in adults1R21DE029746-01SANDERS, ANNE E.UNIV OF NORTH CAROLINA CHAPEL HILL, NC$194,375NAME

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

PA-18-939: Research on Chronic Overlapping Pain Conditions (R21 Clinical Trial Not Allowed) | ScienceDex | ConductScience